Avalon Ventures XI, L.P.

Janux Therapeutics, Inc. · 10% Owner

Avalon Ventures XI, L.P. is listed in filings as 10% Owner at Janux Therapeutics, Inc.. This profile follows SEC Form 4 activity through Oct 18, 2024, including sale activity. Recent filings connect the profile to Janux Therapeutics, Inc. (JANX). The current snapshot covers public activity from Sep 10, 2024 to Oct 18, 2024. Reported amounts are shown as $24.8M to $5.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Latest Trades

CompanyValueActionPriceLast Price
Janux Therapeutics, Inc.JANX$25M553.2k sharesSellOct 18, 2024$44.75$15.84
Janux Therapeutics, Inc.JANX$24M541.8k sharesSellOct 18, 2024$44.75$15.84
Janux Therapeutics, Inc.JANX$5M104.9k sharesSellOct 18, 2024$50.30$15.84
Janux Therapeutics, Inc.JANX$5M102.7k sharesSellOct 18, 2024$50.30$15.84
Janux Therapeutics, Inc.JANX$5M105k sharesSellOct 18, 2024$44.75$15.84
Janux Therapeutics, Inc.JANX$1M19.9k sharesSellOct 18, 2024$50.30$15.84
Janux Therapeutics, Inc.JANX$808k15.8k sharesSellOct 18, 2024$51.18$15.84
Janux Therapeutics, Inc.JANX$791k15.5k sharesSellOct 18, 2024$51.18$15.84
Janux Therapeutics, Inc.JANX$153k3k sharesSellOct 18, 2024$51.18$15.84